Maricel Apuli, Chief Accounting Officer at BridgeBio Pharma, Inc. (BBIO), sold 2,000 shares at $80.06 ($160K) on 2026-07-30, disclosed to the SEC on 2026-08-03.
Scheduled sale ($160k) by Chief Accounting Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| BBIO | SELL | 2026-02-18 | $38K | — | Filing → |
| BBIO | SELL | 2025-12-10 | $149K | — | Filing → |
| BBIO | SELL | 2025-08-11 | $45K | — | Filing → |